Risk factors for long-term invasive mechanical ventilation: a longitudinal study using German health claims data.

"Declarations Ethics approval and consent to participateThe study protocol version 1.0 was first approved by the ethics committee of the Medical Faculty Heidelberg prior to the start of the study (S-352/2018) on 18th September 2020, version 1.4. was approved on 27th April 2021. Data protection is guaranteed in accordance with the European Data Protection Regulation, the Baden-Württemberg State Data Protection Act, and the Federal Data Protection Act. Furthermore, the data protection concept has been reviewed and accepted by the data protection officer of the Heidelberg University Hospital. In accordance with the data protection regulations and the ethics vote, written patient consent was not considered necessary in this contex. Competing interestsIn addition to the stated funding from the Innovation Fund of the Federal Joint Committee (G-BA), FCT reports payment or honoraria for lectures, or reimbursement of travel expenses from Novartis AG, GlaxoSmithKline, Chiesi, Boehringer Ingelheim Gmbh, Grifols and AstraZeneca. JS holds stocks of the aQua Institute for Applied Quality Improvement and Research in Health Care. JDM, BN, JM, MM, AK, CN, AS, FJFH, EB, TF, MW, SB, JSH, TB and TF have no competing interests. Competing interests In addition to the stated funding from the Innovation Fund of the Federal Joint Committee (G-BA), FCT reports payment or honoraria for lectures, or reimbursement of travel expenses from Novartis AG, GlaxoSmithKline, Chiesi, Boehringer Ingelheim Gmbh, Grifols and AstraZeneca. JS holds stocks of the aQua Institute for Applied Quality Improvement and Research in Health Care. JDM, BN, JM, MM, AK, CN, AS, FJFH, EB, TF, MW, SB, JSH, TB and TF have no competing interests."

"Funding Open Access funding enabled and organized by Projekt DEAL. This PRiVENT study is fully funded by the Innovation Fund of the Federal Joint Committee (G-BA), grant number: 01NVF19023."

"Trial registration  The PRiVENT study was retrospectively registered at ClinicalTrials.gov (NCT05260853). Registered at March 2, 2022."